Zivo Bioscience (ZIVO)

$10.00 +0.01 (0.10%)
Market Cap 38.93M
Revenue (ttm) 160,000.00
Net Income (ttm) -13.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,362.50%
Debt to Equity Ratio 0.00
Volume 300
Avg Vol 986
Day's Range N/A - N/A
Shares Out 3.90M
Stochastic %K 59%
Beta 0.18
Analysts Hold
Price Target $12.00

Company Profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 248 452 9866
Address:
2125 Butterfield Drive, Suite 100, Troy, United States
trprofit
trprofit Dec. 3 at 1:38 PM
$ZIVO Yaldo is keepin the light on...for now. WTF is happening ZIVO??
1 · Reply
trprofit
trprofit Nov. 26 at 12:46 PM
$ZIVO Make it happen Yaldo! YOU have the most to lose here.
1 · Reply
nick275
nick275 Nov. 23 at 8:26 PM
$ZIVO CEO Payne has repeated the same pattern that plagued Zivo before he arrived: big promises, firm timelines, and no executed deal. In 2022, Payne said Zivo expected a final call from a leading partner by the end of the second quarter. Nothing happened. In 2023, the company suggested that diligence was nearly complete. Still nothing. By 2024, Zivo pointed to strong data from a key 42-day poultry trial and hinted that negotiations were entering their final phase. Again, no agreement. The latest pledge was that formal talks would begin in January 2025 and wrap up soon after. As of the most recent updates, investors are still waiting. For a CEO whose message centers on operational discipline and commercial readiness, the repeated slips raise questions about how close these deals ever were. Either the counterparties are unconvinced, or Zivo has overestimated its leverage. Both possibilities point to deeper issues.
0 · Reply
nick275
nick275 Nov. 23 at 5:16 PM
$ZIVO price falling and volume increasing. Someone knows something. Is ZIVO withholding material information?
0 · Reply
nick275
nick275 Nov. 23 at 2:17 PM
$ZIVO now in the single digits. Ready to submit an open records request to the University of Delaware to see what is going on with their work with Zivo since Zivo will not communicate with investors.
0 · Reply
nick275
nick275 Nov. 20 at 2:47 PM
$ZIVO still nothing while price approaches single digits. The incompetence is astonishing
1 · Reply
nick275
nick275 Nov. 2 at 11:03 PM
$ZIVO anyone here still holding ? Appears no progress made since CEO letter. So many other opportunities in the market while this has drifted down and been dead money for years.
0 · Reply
nick275
nick275 Oct. 29 at 6:16 PM
$ZIVO and the bid collapses. Just another day in Zivoland
0 · Reply
nick275
nick275 Oct. 28 at 1:00 PM
$ZIVO looks like another week of no news.
0 · Reply
nick275
nick275 Oct. 24 at 5:36 PM
$ZIVO hopefully this gets sold soon. Current management and board are not up to the job.
0 · Reply
Latest News on ZIVO
No data available.
trprofit
trprofit Dec. 3 at 1:38 PM
$ZIVO Yaldo is keepin the light on...for now. WTF is happening ZIVO??
1 · Reply
trprofit
trprofit Nov. 26 at 12:46 PM
$ZIVO Make it happen Yaldo! YOU have the most to lose here.
1 · Reply
nick275
nick275 Nov. 23 at 8:26 PM
$ZIVO CEO Payne has repeated the same pattern that plagued Zivo before he arrived: big promises, firm timelines, and no executed deal. In 2022, Payne said Zivo expected a final call from a leading partner by the end of the second quarter. Nothing happened. In 2023, the company suggested that diligence was nearly complete. Still nothing. By 2024, Zivo pointed to strong data from a key 42-day poultry trial and hinted that negotiations were entering their final phase. Again, no agreement. The latest pledge was that formal talks would begin in January 2025 and wrap up soon after. As of the most recent updates, investors are still waiting. For a CEO whose message centers on operational discipline and commercial readiness, the repeated slips raise questions about how close these deals ever were. Either the counterparties are unconvinced, or Zivo has overestimated its leverage. Both possibilities point to deeper issues.
0 · Reply
nick275
nick275 Nov. 23 at 5:16 PM
$ZIVO price falling and volume increasing. Someone knows something. Is ZIVO withholding material information?
0 · Reply
nick275
nick275 Nov. 23 at 2:17 PM
$ZIVO now in the single digits. Ready to submit an open records request to the University of Delaware to see what is going on with their work with Zivo since Zivo will not communicate with investors.
0 · Reply
nick275
nick275 Nov. 20 at 2:47 PM
$ZIVO still nothing while price approaches single digits. The incompetence is astonishing
1 · Reply
nick275
nick275 Nov. 2 at 11:03 PM
$ZIVO anyone here still holding ? Appears no progress made since CEO letter. So many other opportunities in the market while this has drifted down and been dead money for years.
0 · Reply
nick275
nick275 Oct. 29 at 6:16 PM
$ZIVO and the bid collapses. Just another day in Zivoland
0 · Reply
nick275
nick275 Oct. 28 at 1:00 PM
$ZIVO looks like another week of no news.
0 · Reply
nick275
nick275 Oct. 24 at 5:36 PM
$ZIVO hopefully this gets sold soon. Current management and board are not up to the job.
0 · Reply
ChaseDeluca
ChaseDeluca Oct. 17 at 7:58 AM
VRME The valuation disconnect is glaring: $VRME’s P/Cash Flow is 15× while many peers trade at much higher multiples.  With a golden cross forming and macro rotation into tech/AI, this could be one of the stealth names to watch….. $FTSV $GLMD $ZIVO $GENE
0 · Reply
trollxer
trollxer Oct. 10 at 10:27 AM
$ZIVO 🤔
0 · Reply
trprofit
trprofit Oct. 4 at 1:58 PM
$ZIVO Yaldo is ALL IN and then some........
2 · Reply
nick275
nick275 Oct. 2 at 10:34 PM
$ZIVO on the way to $10 again. Redoubling efforts making a difference
0 · Reply
nick275
nick275 Sep. 26 at 4:06 PM
$ZIVO another week and no news
0 · Reply
nick275
nick275 Sep. 24 at 2:21 PM
$ZIVO Zivo management and board doing an awesome job getting investors interested in the stock.
0 · Reply
AmigoMike
AmigoMike Sep. 23 at 1:59 PM
$ZIVO This is not an application for $100 million. $100 million is the total amount of the grant awards. That $100 million will be carved up and doled out to many companies for which their grant proposal is accepted for funding. The USDA received over 400 submissions for this grant. But Federal gov't fiscal year ends September 30th so I would expect that these awards have to happen in the next week.
1 · Reply
trprofit
trprofit Sep. 22 at 7:47 PM
$ZIVO Application for $100 Million USDA Grant That would be a game changer, eh? https://www.ainvest.com/news/zivo-bioscience-leveraging-strategic-partnerships-disrupt-1-5b-poultry-health-market-2506/ "ZIVO's progress is underpinned by strategic funding and regulatory alignment. The company has applied for a $100 million USDA grant (Avian Influenza Poultry Innovation Grand Challenge) to optimize its formulations and conduct large-scale trials. Additionally, a $5.5 million request to Michigan underscores its focus on advancing LPAI research. These grants not only de-risk development but also align with USDA and FDA requirements for commercialization"
1 · Reply
nick275
nick275 Sep. 19 at 1:36 PM
$ZIVO over a week since the fluff letter and silence.
1 · Reply
nick275
nick275 Sep. 15 at 2:33 AM
$ZIVO it appears the shareholder letter convinced no one to pick up shares. Fluff is not going to move this stock after shareholders were told there would be a signed deal months ago. Finally sign an agreement that brings much needed cash.
0 · Reply
AmigoMike
AmigoMike Sep. 10 at 5:52 PM
$ZIVO https://ir.zivobioscience.com/sec-filings-email/content/0001654954-25-010579/zivo_ex991.htm
0 · Reply
AmigoMike
AmigoMike Sep. 10 at 5:39 PM
$ZIVO shareholder letter posted today. Not bad, not all that investors are looking for however.
1 · Reply